Kisho

Kisho is an information platform, not a medical provider. Nothing on this site constitutes medical advice, diagnosis, or treatment recommendations. All content is aggregated from publicly available sources (including ClinicalTrials.gov, PubMed, FDA.gov, and Orphanet) and is provided for informational purposes only. Clinical trial eligibility, treatment decisions, and any health-related actions should always be discussed with a qualified healthcare professional. Kisho does not endorse any specific therapy, organization, or clinical trial. Terms of use · Privacy policy

cutaneous leishmaniasis - Clinical Profile, Genes & Research | Kisho | Kisho

Rare Disease

cutaneous leishmaniasis

MONDO:0005446

Also known as:Asian desert cutaneous leishmaniasisleproid leishmaniasiszone of skin leishmaniasis

Find Clinical TrialsTrials

Overview

Leishmaniasis affecting the skin. It is the most common form of leishmaniasis. It presents with erythematous macules and papules, and nodules which may eventually ulcerate. The lesions appear in the bite site in the exposed skin areas.

TreatmentsNo approved treatments · 4 in pipeline

Clinical Trials11 registered · 6 recruiting

Diagnosis

Biomarker and diagnostic research for cutaneous leishmaniasis has been reported in the published literature.

Treatment

Compiled from FDA-approved drug records, orphan drug designations, and FDA Adverse Event Reporting System (FAERS) safety data. GeneReviews management guidance is included where available.

No approved treatments are currently available for cutaneous leishmaniasis. An additional 4 compounds hold orphan drug designation.

Orphan Drug Designations

While no drugs are FDA-approved specifically for cutaneous leishmaniasis, some of the following designated compounds may be used off-label in clinical practice. Treatment decisions should be made in consultation with a specialist familiar with this condition.

The following drugs have received orphan drug designation from the FDA for cutaneous leishmaniasis. Orphan designation reflects regulatory interest and does not indicate approval for treatment.

Brand Name	Generic Name	Sponsor

Research Landscape

Sourced from ClinicalTrials.gov and PubMed. Publication types are classified using NLM-curated article metadata; research type breakdowns reflect the nature of published work for this disease.

11 clinical trials registered, 6 recruiting. Interventions under study include drug therapy, other interventions, and medical devices. Pipeline includes 1 PHASE3, 5 PHASE2, 1 PHASE1. Research is primarily sponsored by academic and government institutions.

NCT ID	Title	Phase	Sponsor	Status
[NCT06798415](https://clinicaltrials.gov/study/NCT06798415)

Data assembled from 4 of 12 sources · Last updated Sep 19, 2026, 11:55 PM UTC

MONDOHPOClinicalTrials.govFDAPubMedHGNCClinVarClinGenGeneReviewsOrphanetOMIMRUSP

Medical References

Questions for Your Care Team

→Are any of the 11 active clinical trials a good fit for my situation?
→With 4 compounds in the orphan drug pipeline, which are furthest along in development and which clinical trials should I be aware of?
→Are there specialists or centers of excellence for this condition in my area?
→Is there a patient registry I should consider joining?

← Back to All Diseases

Research Type	Count	% of Total
Disease patterns and progression	66	28%
Research summaries	46	19%
Laboratory research	43	18%
Patient case studies	34	14%
New treatment approaches	18	8%
Testing and diagnosis research	14	6%
Clinical study results	12	5%
Other research	7	3%

Kisho

cutaneous leishmaniasis

Overview

Diagnosis

Treatment

Orphan Drug Designations

Research Landscape

Medical References

Questions for Your Care Team

Questions for Your Care Team

Clinical Trials

Recent Publications

Latest News & Developments

Cutaneous leishmaniasis arising in a latent dermal sinus causing a dermoscopic dilemma.

cutaneous leishmaniasis

Overview

Diagnosis

Treatment

Orphan Drug Designations

Research Landscape

Medical References

Subtypes

Related Diseases

Questions for Your Care Team

Questions for Your Care Team

Clinical Trials

Recent Publications

Latest News & Developments

Cutaneous leishmaniasis arising in a latent dermal sinus causing a dermoscopic dilemma.